Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Publication year range
1.
Article in English | MEDLINE | ID: mdl-38595321

ABSTRACT

BACKGROUND: Data on dermatological manifestations of Costello syndrome (CS) remain heterogeneous and lack in validated description. OBJECTIVES: To describe the dermatological manifestations of CS; compare them with the literature findings; assess those discriminating CS from other RASopathies, including cardiofaciocutaneous syndrome (CFCS) and the main types of Noonan syndrome (NS); and test for dermatological phenotype-genotype correlations. METHODS: We performed a 10-year, large, prospective, multicentric, collaborative dermatological and genetic study. RESULTS: Thirty-one patients were enrolled. Hair abnormalities were ubiquitous, including wavy or curly hair and excessive eyebrows, respectively in 68% and 56%. Acral excessive skin (AES), papillomas and keratotic papules (PKP), acanthosis nigricans (AN), palmoplantar hyperkeratosis (PPHK) and 'cobblestone' papillomatous papules of the upper lip (CPPUL), were noted respectively in 84%, 61%, 65%, 55% and 32%. Excessive eyebrows, PKP, AN, CCPUL and AES best differentiated CS from CFCS and NS. Multiple melanocytic naevi (>50) may constitute a new marker of attenuated CS associated with intragenic duplication in HRAS. Oral acitretin may be highly beneficial for therapeutic management of PPHK. No significant dermatological phenotype-genotype correlation was determined between patients with and without HRAS c.34G>A (p.G12S). CONCLUSIONS AND RELEVANCE: This validated phenotypic characterization of a large number of patients with CS will allow future researchers to make a positive diagnosis, and to differentiate CS from CFCS and NS.

2.
Am J Dermatopathol ; 34(7): 699-705, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22481495

ABSTRACT

Self-healing juvenile cutaneous mucinosis (SHJCM) is a rare disorder of unknown origin, which occurs in children in good health. It is characterized by the multiplication of transient cutaneous papules and nodules, mainly located on the head and periarticular areas that spontaneously resolve. Histological features of SHJCM have been well described; therefore, the diagnosis is usually made easily when papules are biopsied. We report a series of 3 new cases of SHJCM presenting mainly with nodular lesions. Histological examination of these nodules showed either lesions consistent with nodular or proliferative fasciitis or nonspecific panniculitis. Mucinous deposits were present but often inconspicuous, so could be disregarded. We wanted to emphasize this misleading presentation because a biopsy for histological examination is always mandatory in cases of proliferating nodules to rule out malignant tumors. Therefore, the diagnosis always requires discussion between pathologists and clinicians to rapidly reassure the parents and avoid inappropriate therapy.


Subject(s)
Cell Proliferation , Diagnostic Errors/prevention & control , Mucinoses/pathology , Mucins/analysis , Skin Neoplasms/pathology , Skin/pathology , Biomarkers/analysis , Biopsy , Child, Preschool , Fasciitis/etiology , Fasciitis/pathology , Humans , Immunohistochemistry , Infant , Male , Mucinoses/complications , Mucinoses/metabolism , Panniculitis/etiology , Panniculitis/pathology , Predictive Value of Tests , Remission, Spontaneous , Skin/chemistry , Time Factors
3.
J Biol Chem ; 287(5): 3462-78, 2012 Jan 27.
Article in English | MEDLINE | ID: mdl-22139845

ABSTRACT

Transcriptional mechanisms regulating type I collagen genes expression in physiopathological situations are not completely known. In this study, we have investigated the role of nuclear factor-κB (NF-κB) transcription factor on type I collagen expression in adult normal human (ANF) and scleroderma (SF) fibroblasts. We demonstrated that NF-κB, a master transcription factor playing a major role in immune response/apoptosis, down-regulates COL1A1 expression by a transcriptional control involving the -112/-61 bp sequence. This 51-bp region mediates the action of two zinc fingers, Sp1 (specific protein-1) and Sp3, acting as trans-activators of type I collagen expression in ANF and SF. Knockdown of each one of these trans factors by siRNA confirmed the trans-activating effect of Sp1/Sp3 and the p65 subunit of NF-κB trans-inhibiting effect on COL1A1 expression. Despite no existing κB consensus sequence in the COL1A1 promoter, we found that Sp1/Sp3/c-Krox and NF-κB bind and/or are recruited on the proximal promoter in chromatin immunoprecipitation (ChIP) assays. Attempts to elucidate whether interactions between Sp1/Sp3/c-Krox and p65 are necessary to mediate the NF-κB inhibitory effect on COL1A1 in ANF and SF were carried out; in this regard, immunoprecipitation assays revealed that they interact, and this was validated by re-ChIP. Finally, the knockdown of Sp1/Sp3/c-Krox prevents the p65 inhibitory effect on COL1A1 transcription in ANF, whereas only the siRNAs targeting Sp3 and c-Krox provoked the same effect in SF, suggesting that particular interactions are characteristic of the scleroderma phenotype. In conclusion, our findings highlight a new mechanism for COL1A1 transcriptional regulation by NF-κB, and these data could allow the development of new antifibrotic strategies.


Subject(s)
Collagen Type I/biosynthesis , DNA-Binding Proteins/metabolism , Dermis/metabolism , Fibroblasts/metabolism , Response Elements , Scleroderma, Localized/metabolism , Sp1 Transcription Factor/metabolism , Sp3 Transcription Factor/metabolism , Transcription Factor RelA/metabolism , Transcription Factors/metabolism , Transcription, Genetic , Adult , Child , Child, Preschool , Collagen Type I/genetics , Collagen Type I, alpha 1 Chain , DNA-Binding Proteins/genetics , Dermis/pathology , Fibroblasts/pathology , Gene Expression Regulation/genetics , Humans , Male , Scleroderma, Localized/pathology , Sp1 Transcription Factor/genetics , Sp3 Transcription Factor/genetics , Transcription Factor RelA/genetics , Transcription Factors/genetics
4.
Ann Pathol ; 31(1): 36-40, 2011 Feb.
Article in French | MEDLINE | ID: mdl-21349387

ABSTRACT

Mycosis fungoids can present with various clinical and histological features, with only a few of them being recognized as distinct entities in the current WHO and EORTC classifications. Histologically, mycosis fungoids (MF) usually show a superficial perivascular or band-like lymphocytic infiltrate with epidermotropism. We here report two cases of a rare histological variant of MF, called interstitial in the literature. Our first patient, a 71-year-old male, had a previously diagnosed MF, which clinically evolved towards nodules, showing histologically an interstitial lymphocytic infiltrate without epidermotropism and without large cell transformation. The second patient was a 64-year-old female with widespread plaques and nodules. Histologically, a dense dermal interstitial infiltrate was observed, with foci of epidermotropism, without large cell transformation. At relapse after treatment, she presented with plaques, papules and nodules, histologically showing a slight interstitial lymphocytic infiltrate that resembled granuloma annulare or inflammatory morphea. In both patients, clinical aspect suggested MF and a dominant T-cell clone was found in lesional skin. Nodules in MF are not always the hallmark of large cell transformation, but may correspond to unusual interstitial lesions. Diagnosis of such rare variant may be difficult and requires a good clinical pathological correlation together with the search for foci of epidermotropism on skin biopsy and for a dominant cutaneous T-cell clone.


Subject(s)
Mycosis Fungoides/pathology , Skin Neoplasms/pathology , Aged , Anti-Inflammatory Agents/therapeutic use , Antirheumatic Agents/adverse effects , Arthritis, Rheumatoid/complications , Arthritis, Rheumatoid/drug therapy , Biopsy , Clobetasol/therapeutic use , Female , Humans , Immunophenotyping , Male , Methotrexate/adverse effects , Middle Aged , Mycosis Fungoides/classification , Mycosis Fungoides/drug therapy , Neoplasm Recurrence, Local , PUVA Therapy , Skin Neoplasms/classification , Skin Neoplasms/drug therapy , T-Lymphocyte Subsets/chemistry , T-Lymphocyte Subsets/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...